Dr. David A Axelrod, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1620 S Queen St, York, PA 17403 Phone: 717-843-6663 Fax: 717-852-0670 |
Dr. Joyce Kopicky Burd, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 292 Saint Charles Way, York, PA 17402 Phone: 717-851-6236 Fax: 717-851-6243 |
Karan Chawdhary, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 292 Saint Charles Way, York, PA 17402 Phone: 717-851-6236 Fax: 717-741-1614 |
Nihad Yasmin, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 |
Dr. Carole Dorsch, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2021 Garnet Rd, York, PA 17403 Phone: 717-845-4007 |
News Archive
Texas Tech University Health Sciences Center researcher Afzal A. Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor at the TTUHSC School of Medicine, received a $3.82 million grant from the National Institutes of Health (NIH).
The latest research for sports-related concussion and sudden cardiac death in athletes, in addition to a record number of sports medicine research submissions, will be presented by members of the American Medical Society for Sports Medicine at the 2013 AMSSM Annual Meeting.
A simple blood test is allowing Vanderbilt University Medical Cente researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
University of Maryland researchers have explained, for the first time, why the linkage between the cell-regulating protein molecules called ubiquitins determines their function.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 9 days ago